Rapid health technology assessment of anlotinib in treatment of advanced non-small cell lung cancer

Objective To evaluate the efficacy, safety and cost-effectiveness of anlotinib in treatment of advanced non-small cell lung cancer (NSCLC) by rapid health technology assessment.Methods CNKI, Wanfang database, SinoMed, PubMed, The Cochrane Library and Embase were electronically searched to collect hi...

Full description

Saved in:
Bibliographic Details
Main Authors: Shan SHEN, Jie YANG, Yun-Xia LIU, Hai-Ming MA, Ning HOU
Format: Article
Language:zho
Published: Editorial Office of New Medicine 2021-10-01
Series:Yixue xinzhi zazhi
Subjects:
Online Access:https://yxxz.whuznhmedj.com/storage/attach/2110/DL8KBSV8GFyt18BAHPNlXjx4YnyZSNLIKy40xPH7.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!